Brett Belongia
Corporate Officer/Principal bei ONCORUS, INC.
Profil
Brett Belongia is currently working as Vice President-CMC Operations at Oncorus, Inc. He previously worked as Director-Technical Operations at Momenta Pharmaceuticals, Inc. Dr. Belongia completed his undergraduate degree from the University of Wisconsin and his doctorate degree from the University of Arizona.
Aktive Positionen von Brett Belongia
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCORUS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Brett Belongia
| Unternehmen | Position | Ende |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Brett Belongia
| University of Arizona | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCORUS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
